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S U M M A R Y  
Using a monoclonal antibody to H-Y antigen we characterized the molecular 
determinant responsible for H-Y reactivity. H-Y-positive cells were treated with 
enzymes which alter carbohydrate structure and then were tested for their ability 
to absorb monoclonal anti-H-Y antibody. Indications are that the serological 
determinant recognized by this antibody is a glycoconjugate containing terminal 
non-reducing and internal galactosyl residues. 
I N T R O D U C T I O N  
H-Y antigen is a minor histocompatibility antigen serologically detectable on the surfaces 
of cells from the heterogametic sex of a variety of vertebrate species (Wachtel, 1979; Ohno 
and Matsunaga, 1981) and even on cells from invertebrates (Shalev et al., 1980). In 
mammals H-Y is found almost exclusively in males, and, as such, has been postulated to 
play a role in primary sex determination (for a review, see Ohno, 1979). 
H-Y is a weak antigen. Conventional H-Y antisera have low titres, are cytotoxic against 
few cell types and are not readily used in test systems such as ELISA and 
radioimmunoassay. Different laboratories studying H-Y use antisera raised differently and 
a variety of detection methods, a situation which makes the comparison of independently- 
derived experimental results difficult (Goodfellow and Andrews, 1982). 
The availability of monoclonal anti-H-Y antibodies may resolve some of these 
difficulties. We report here the production of a monoclonal anti-H-Y antibody which is 
male-specific on the basis of its pattern of reactivity both in an indirect cellular 
radioimmunobinding assay and in a direct cytotoxicity test against isolated mouse 
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epidermal cells in the presence of complement. To  characterize the molecular determinant 
responsible for this pattern of reactivity, H-Y-positive cells were treated with enzymes 
which alter terminal or internal carbohydrate structures and then tested for their ability to 
absorb the monoclonal anti-H-Y antibody. We provide evidence that the determinant 
recognized by this antibody is a glycoconjugate containing both terminal non-reducing and 
internal galactosyl residues. 
M A T E R I A L S  A N D  M E T H O D S  
Animals 
C57BL/6 (B6) mice were bred from a stock obtained from the Jackson Laboratories, 
Bar Harbor, Maine, U.S.A. F344 rats were obtained from the Charles River Breeding 
Laboratories, Wilmington, Maine, U.S.A. 
Cell lines 
University of New Mexico. It is a BALB/c line known not to secrete immunoglobulin. 
Preparation of epidermal cells 
Epidermal cells were prepared by the method of Scheid et al. (1972). Mature male B6 
mice were killed and the entire piece of skin covering the tail removed. The tail skin was 
incubated in Puck’s Saline F (PSF) containing 1% trypsin (2 x crystallized, Gibco) for 
50 min at 37OC in order to separate dermis and epidermis. The dermis was discarded and 
the epidermis placed in Medium 199 (M 199, Gibco) containing 10% heat-inactivated 
(56OC, 30 min) gammaglobulin free foetal calf serum (FCS). Epidermal cell clumps were 
teased free of the epidermis by gentle scraping with the tip of a bent, fire-polished pasteur 
pipette. These clumps were incubated in PSF containing 0.1% trypsin for 15-20 min at 
37°C in order to yield a suspension of single cells. After incubation, a twofold excess of 
M199 with 10% FCS was added to the incubation mixture. Free cells were pelleted by 
centrifugation at 100 g for 10 rnin at 4OC, then washed three times in MI99 containing 
10% FCS. Clumps of cells were removed by centrifugation at 10-20 g for 5 rnin. The 
final suspension of epidermal cells was then adjusted to a concentration of approximately 
3 x lo6 cells per ml for use in the direct cytotoxicity test. 
Preparation of splenocytes 
Mature mice were killed and their spleens removed. The spleens were placed in 
Dulbecco’s phosphate-buffered saline (PBS), minced, and teased through a screen. The 
suspension was left for 10 min to enable large-sized stromal elements to sediment. 
Splenocytes were pelletted by centrifugation at 400 g for 10 rnin and the pellet washed 
twice in 0.83% NH,Cl, then twice in PBS. 
Preparation of antisera 
(1) Rat anti-H-Y antiserum was prepared by the method of Fellous et al. (1 978) by 
immunizing female F344 rats with male (F344) splenocytes. Prior to use in this experiment 
all antisera were heat-inactivated (56OC, 30 min) and absorbed with equal volumes of 
female mouse splenocytes, first for 1 h at OOC, then for 1 h at 37°C. An antiserum was 
judged specific for H-Y if (1) it had cytotoxic activity against male, but not female B6 
epidermal cells and (2) this activity could be absorbed by male, but not female B6 
splenoc ytes. 
The mouse plasmacytoma P3-NSI/l-Ag4-1 was obtained from Dr Noel Warner, 
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(2) H-2b antisera, directed against H-2.33 (D-33) and H-2.2 (D2), were obtained from 
the Transplantation Immunology Branch of the National Institutes of Health, Bethesda, 
Maryland, U.S.A. 
(3) 1251-labelled sheep anti-mouse kappa antibody. Sheep anti-mouse kappa serum 
was kindly provided by Dr Noel Warner, University of New Mexico. The IgG fraction of 
the antibody was purified by affinity chromatography on a mouse IgG column by Dr 
K. S. K. Tung, University of New Mexico. The antibody was labelled with Na1251 
(Amersham) at 0.1 mCi/mg by the chloramine T method (Greenwood et al., 1963). 
Direct cytotoxicity test 
The procedure used to test H-Y antisera is similar to that of Scheid et al. (1972). Equal 
volumes (10 p l )  of H-Y antiserum, epidermal cells (3 x lo6 per ml), and guinea-pig 
complement (Gibco) diluted 1/16 were incubated at 37°C for 50 min. Trypan blue (10 p1 
of a 0.2% solution) was added for the final 5 min of incubation to stain dead epidermal 
cells. Cell killing was measured by cytotoxic index (i) defined as: 
Number of dead cells in test sample - number of cells killed by complement alone 
Total number of cells - number of cells killed by complement alone 
Ar1ti-H-2~ antisera were tested for direct cytotoxicity against splenocytes in the following 
manner. Equal aliquots (10 p l )  of a11ti-H-2~ antiserum and B6 splenocytes (8 x lo6 per ml) 
were incubated for 20 min at room temperature. Ten microlitres of baby rabbit serum (Pel 
Freez) as a source of complement diluted 1/4 was then added and the suspension incubated 
at 37OC for a further 35 min. Ten microlitres of 0.2% trypan blue was added for the final 5 
min of incubation to stain dead splenocytes. Formalin saline (10 pl containing 5% 
formaldehyde) was added as a fixative and live and dead cells were counted. Cell killing 
was measured by cytotoxic index ( i) .  All cytotoxicity tests were run on coded samples. 
Absorptions 
Aliquots of anti-H-Y antiserum (25 pl) diluted 1/4 were added to known numbers of 
splenocytes. Suspensions were incubated at 4OC for 1 hr. Next the absorbing cells were 
removed from the absorbed antiserum by centrifugation at 400 g for 10 min at 4OC. The 
resultant antiserum was then tested for residual direct cytotoxicity against isolated male 
mouse epidermal cells. 
Enzyme treatments 
Sensitivity of H-Y specific absorption to all treatment is expressed as: 
A - B  
C - B  
Corrected % inhibition of absorption = x loo! 
where A = i of male cells treated with anti-H-Y antibody previously absorbed with enzyme 
treated male cells, B = i of male cells treated with anti-H-Y antibody previously absorbed 
with male cells which were not subject to enzyme treatment, and C = i of male cells treated 
with anti-H-Y antibody which had not been absorbed. 
Galactose oxidase (Sigma) was dissolved in PBS containing 1 .O mg per ml of bovine 
serum albumin (BSA, Sigma). Spienocytes were incubated with known amounts of enzyme 
in PBS (pH 7.4) at 37°C for 1 hr. Each incubation mixture contained 4 x lo7 splenocytes 
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plus enzyme in a volume of 0.5 ml. After incubation, treated cells were washed three times 
in MI99  supplemented with 10% FCS and I M galactose prior to absorption. 
Purified endo-P-galactosidase (3.0 units/mg protein) from E. frendii was the gift of Dr 
M. N. Fukuda, Fred Hutchinson Cancer Center, Seattle, Washington, U.S.A. Splenocytes 
( lo7 in the case of the H-2b assays or 4 x 10' in that of the H-Y system) were treated in 0.5 
ml incubation volumes containing 0- 1 M acetate buffer, 0 -07  M NaC1, and 0.0625 units of 
endo-P-galactosidase at pH 5.8 for 2 hr at 37OC. Following treatment, cells were washed 
three times in MI99 containing 10% FCS at 4OC prior to absorption. 
Untreated control samples were handled in a manner identical to treated cells, with the 
exception that the appropriate enzyme was omitted from the incubation mixture. 
'2sI-radioirnmunobinding assay 
The radioimmunobinding assay used was a modification of that described by Tsu and 
Herzenberg (1980). Briefly, single cell suspensions of B6 male or female lymph node 
lymphocytes were prepared in PBS. After washing three times with PBS by centrifugation 
at 200 g, they were suspended in PBS at a concentration of 10 x lo6 cells/ml. Fifty 
microlitres of the appropriate cell suspension were added to each well of a soft plastic 
microtitre plate (Dynatech Laboratories) that had previously been coated with bovine 
serum albumin (BSA) made 3% with PBS. Fifty microlitres of antiserum diluted in PBS 
(1/2-1/128, at doubling dilutions) were then added to triplicate wells of both male and 
female cells. After incubating the plate for 30 min at 4OC, it was washed three times with 
BSA made 0.2% with PBS, by centrifugation at 200 g for 10 min. The 1251-labelled sheep 
anti-mouse kappa antibody, diluted in 3% BSA, was then added to each well in SO p l  
volumes to give 1-2 x lo5 counts per well. After incubating for 30 min at room 
temperature, the plate was washed five times and allowed to dry. The amount of lZ5I bound 
to the cells in each well was determined and was expressed as a percentage of the 
male :female binding according to the following formula: 
lZsI cpm (male) - lZsI cprn (female) 
lZsI cpm (male) 
x 100% 
R E S U L T S  
To generate the hybridoma by which the monoclonal anti-H-Y antibody is produced, 10 B6 
female mice were immunized with B6 male splenocytes. After immunization, the B6 
females were screened for the production of anti-H-Y antibodies by cytotoxicity against B6 
spermatozoa in the presence of complement (Goldberg et al., 1970). The two females most 
positive for anti-H-Y antibody production were killed, and their splenocytes prepared for 
fusion with P3-NSI/l-AG4-1 cells, using standard techniques for cell fusion and for 
maintenance and cloning of hybridomas (Kohler & Milstein, 1975: Oi & Herzenberg, 
1980). The supernatants of generated clones were screened for anti-H-Y antibody 
production by the cellular radioimmunobinding assay and, of 100 clones tested, only a 
single clone produced male-specific antibody. 
The positive clone was subcloned by limiting dilution to yield five subclones. 
Supernatants were collected from the subclones and tested by cellular radioimmuno- 
binding for preferential binding to male lymphocytes. Antibodies from three subclones, 1, 2 
and 4, showed significantly more binding to male than to female mouse lymphocytes, 
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TABLE 1. Screening of hybridoma subclone super- 
natants 
(a) 1251-radioimmunobinding test against B6 male and 
female lymph node lymphocytes 
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ltS1 (cpm) bound to*: Per cent 
male :female 
Subclone Male Female differencet 
1 1,609 986 38.7 
2 1,035 339 67.2 
3 4,750 4,674 1.6 
4 9,7 15  7.264 25.2 
5 7,394 7,313 1 .  I 
(b) Cytotoxicity tests on B6 male and female epidermal 
cells 
Subclone Male Female 
1 0.13 t 0.01 0.03 0.03 
2 0.18 _+ 0.02 0.04 _+ 0.02 
3 0.02 i: 0.01 N D  
4 0.09 2 0 0.02 2 0.01 
5 0.03 F 0.02 ND 
* Each value represents the average of five experi- 
ments. Supernatant was diluted 1/16 at which the 
greatest percentage of' 1251 was obtained. The cpm 
bound to the target cells using '251-labelled sheep anti- 
mouse kappa antibody ranged from 100 to 250. 
t See formula given in text. 
$ Each value of mean cytotoxic index. i, represents 
the mean of tests performed at three dilutions of super- 
natant ( I  : 2. I : 4  and 1 : 8 ? SEM). 
whereas those from subclones 3 and 5 did not (Table la). The supernatants were also 
independently tested for direct cytotoxicity against isolated B6 male epidermal cells. In this 
test the supernatants of subclones 1, 2 and 4 had cytotoxic activity against male epidermal 
cells, whereas supernatants 3 and 5 were not significantly more active than complement 
alone (Table lb). In both assays supernatant 2 was more active than 1 or 4. A 
representative test using supernatant from subclone 2 is illustrated in Fig. 1. 
Supernatants 1, 2 and 4 were tested for cytotoxic activity against male and female B6 
epidermal cells. Fig. 2a shows the pooled data from these cytotoxicity tests presented as a 
graph of cytotoxic index (i) versus the reciprocal of antibody dilution. The data indicate 
that the monoclonal antibody is significantly more cytotoxic against male than female 
epidermal cells. 
As another test of male specificity, we determined whether the antibody's cytotoxic 
activity against male epidermal cells could be preferentially absorbed by male splenocytes. 
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FIG. 1. Detection of H-Y on B6 male epidermal cells by the cytotoxicity test using monoclonal 
anti-H-Y antibody (subclone 2). (A-A) male target cells; (0-0) female target cells. (A, 0) 
killing of male, female cells in absence of monoclonal antibody, i.e. by complement alone. 
Supernatants from the three positive subclones were pooled. Aliquots of this antibody 
solution were diluted and absorbed with known numbers of male and female B6 
splenocytes. Absorbed samples were then tested for residual cytotoxic activity against B6 
male epidermal cells. Fig. 2b shows a graph of cytotoxic index versus number of absorbing 
cells. The data indicate that although the cytotoxic activity of the antibody is not 
appreciably removed by female splenocytes, it can be quantitatively absorbed by male 
splenocytes. 
In an attempt to further characterize the molecular determinant recognized by the 
monoclonal anti-H-Y antibody, we examined whether the ability of H-Y+ cells to absorb 
the monoclonal anti-H-Y antibody could be perturbed by treatments which alter 
carbohydrate structure. We endeavoured to see whether one such treatment, the enzyme 
galactose oxidase, could inhibit the ability of H-Y-positive cells to absorb the monoclonal 
antibody. Galactose oxidase oxidizes terminal galactosyl residues at the non-reducing ends 
of a carbohydrate chain. 
Male splenocytes were treated with purified galactose oxidase, then washed in protein 
and sugar-enriched medium before absorption. Treated splenocytes were used to absorb 
aliquots of monoclonal anti-H-Y antibody. Fig. 3 shows a graph of corrected per cent 
inhibition of absorption versus units of enzyme used for treatment. Absorption of the 
monoclonal antibody is sensitive to galactose oxidase. The maximum treatment employed 
(10 units) removes 69% of the absorptive capacity of male mouse splenocytes. This result 
is consistent with results obtained with conventional anti-H-Y antiserum (Shapiro and 
Erickson, 198 1). 
To  further extend these observations, we assessed whether H-Y serological activity was 
affected by the perturbation of internal galactosyl residues. Splenocytes were treated with 
endo-P-galactosidase, an enzyme which hydrolyzes glycosidic linkages of galactosyl 
moieties located proximal to the non-reducing residue of a carbohydrate chain. The cells 
were then washed in protein supplemented medium. Treated cells were used to absorb 
either conventional rat anti-H-Y antiserum or monoclonal anti-H-Y antibody. As a control 
the same treatment was performed on absorbing cells possessing antigens of the H-Zb 
haplotype. H-2 serological determinants are thought to reside in amino acid sequences 
(Nathenson and Muramatsu, 197 1; Pancake and Nathenson, 1973). Whereas H-2b specific 
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FIG. 2. (a) Cytotoxic specificity of monoclonal anti-H-Y antibody. Cytotoxic index. i (as 
defined in Materials and Methods), and reciprocal of antibody dilution used, are indicated on 
the figure. Values shown reprsent the means of triplicate determinations & SEM. (b) Absorption 
specificity of monoclonal anti-H-Y antibody. Cytotoxic index, i, and numbers of spleen cells 
used to absorb each aliquot of hybridoma supernatant (25 pl of a 1 : 4 dilution) are indicated on 
the figure. Values shown represent the means of duplicate determinations. ( S O )  male 
(epidermal) target cells (Fig. 2a) and male (spleen) absorbing cells (Fig. 2b). (0---0) female 
(epidermal) target cells (Fig. 2a) and female (spleen) absorbing cells (Fig. 2b). 
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absorption is completely insensitive to endo-P-galactosidase, H-Y serological activity is 
inhibited by this treatment (Table 2). Absorption of conventional rat anti-H-Y antiserum 
was reduced by 67% and monoclonal anti-H-Y antibody by 69%. 
Considered together, the data from both enzyme treatments suggest that serological 
recognition of H-Y antigen is dependent upon the integrity of a carbohydrate sequence 
containing internal as well as terminal non-reducing galactosyl residues. 
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FIG. 3. Monoclonal anti-H-Y antibody: sensitivity of H-Y-specific absorption to galactose 
oxidase treatment. Corrected percent inhibition of absorption (as defined in Materials and 
Methods) and number of units of enzyme used for treatment are indicated on the figure. Values 
shown represent the means of triplicate determinations 2 SEM. (Representative test.) Also, see 
legend to Table 2. 
TABLE 2. H-Y-specific absorption: sensitivity to endo-B 
galactosidase treatment* 
Percent 
Antibody inhibition of 
dilution absorption 
Antibody used (mean It SEM) 
Rat anti-H-Y 1 : 4  6 7 + 4  
Monoclonal anti-H-Y 1:4 69 i- 4 t  
Ar1ti-H-2~ 1 : 100 4 5 1  
* Endo-b-galactosidase treatments were as described in 
Materials and Methods. Values shown represent the means 
of quadruplicate (H-Y-specific absorption) or duplicate 
(H-2b-specific absorption) determinations & SEM. 
t The percentage of dead cells obtained with mono- 
clonal anti-H-Y supernatant previously absorbed with 
enzyme-treated male cells was 26-37Y0 higher than that 
obtained when the supernatant was absorbed with 
untreated male cells. 
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D I S C U S S I O N  
Our monoclonal anti-H-Y antibody is characterized as H-Y-specific on the basis of its 
pattern of reactivity in an indirect cellular radioimmunobinding assay and a direct 
cytotoxicity test in the presence of complement. In the latter test, serological activity is also 
shown to be absorbed by male, but not female mouse splenocytes, providing additional 
evidence of H-Y specificity. 
In an attempt to further characterize the molecular determinant recognized by this 
antibody, H-Y-positive cells were treated with galactose oxidase and then tested for their 
ability to absorb monoclonal anti-H-Y antibody. In this experiment the absorptive capacity 
of H-Y-positive splenocytes is reduced by galactose oxidase treatment, a result consistent 
with data presented elsewhere using conventional rat anti-H-Y antiserum (Shapiro and 
Erickson, 198 1). This supports the notion that H-Y-specific absorption is dependent upon 
a carbohydrate containing a terminal non-reducing galactosyl residue. 
It should be noted that in the earlier experiment galactose oxidase diminished the ability 
of treated cells to absorb conventional rat anti-H-Y antiserum by, at most, 38%, a value 
considerably less than the 69% inhibition obtained using the monoclonal antibody. This 
difference may reflect intrinsic variation in the experiment, since variation in the percent 
inhibition measured is a composite of variation in galactose oxidase treatment, absorption 
of the antibody, and the direct cytotoxicity test. However, we consider this explanation 
unlikely because the values of percent inhibition of absorption varied by no more than 15% 
in this experiment. A more plausible explanation is that conventional anti-H-Y sera contain 
a repertoire of distinct antibody molecules of which this monoclonal antibody represents 
only one. It is likely that the production of further monoclonal anti-H-Y antibodies will 
generate reagents capable of reacting with carbohydrates of different apparent specificity, 
or amino acid determinants. Determinants of carbohydrate and amino acid character are 
reported to be recognized by a panel of monoclonal antibodies to murine Ia antigens 
(Higgins et al., 1980). 
To  further examine the dependence of H-Y serological activity on carbohydrate 
structure, H-Y positive splenocytes were treated with endo-B-galactosidase, which 
hydrolyzes internal /?-galactosidic linkages. This enzyme inhibits the ability of treated 
splenocytes to absorb both conventional rat antiserum and the monoclonal anti-H-Y 
antibody. This suggests that H-Y serological determinants are either dependent upon or 
attached via internal galactosyl residues within a polysaccharide structure. Unlike the case 
of galactose oxidase treatment, absorption of both reagents appears to be inhibited at the 
same level in endo-/-galactosidase treated cells. Further, this level of inhibition is 
comparable to that observed when galactose oxidase treated cells are used to absorb 
monoclonal anti-H-Y antibody. If indeed both reagents are recognizing a carbohydrate 
sequence, the monoclonal antibody may be one of a number of distinct immunoglobulin 
molecules each of which recognizes a carbohydrate structure bearing multiple determi- 
nants. If these determinants were all physically linked to an internal galactosyl moiety, yet 
only a subset of them contained a terminal non-reducing galactose, one could account for 
the observation that galactose oxidase interferes with absorption of the monoclonal 
anti-H-Y antibody more than that of the conventional, presumably multispecific, reagent. 
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